Advertisement

Payer

Richard Migliori, MD, executive vice president of medical affairs and chief medical officer at UnitedHealth Group, and Margaret-Mary Wilson MD, executive vice president and associate chief medical officer at UnitedHealth, outlined several long-term care strategies during a June 16 call.

Brain cancer drug Gleostine is no longer available for coverage under Medicare Part D after its seller, Miami-based NextSource Biotechnology, removed it from the program, according to The Wall Street Journal.

Advertisement

Point32Health is the name of a new health insurance organization formed by the merger of Tufts Health Plan and Harvard Pilgrim Health Care. 

Civica Rx named the unit that will be tasked with lowering the cost of certain generic medicines, and said one of the nation's largest health insurers — Anthem — will join it.

Advertisement